search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Health Care Professionals, Have You Heard About FLUAD


A flu vaccine for adults 65+.1 FLUAD ®


is the first FDA-approved seasonal flu shot made with


an immune-enhancing adjuvant, which is proven to provide a strong immune response in adults 65 and older.1,2


78 %


of flu-related hospitalizations were for adults 65+ in the US during the 2014–15 flu season3


87+


doses distributed in countries where FLUAD® is licensed4


Help adults 65+ prepare for flu season. The CDC recommends FLUAD® as an acceptable option to other vaccines licensed


Pre-order FLUAD® .


(or indicated) for people 65 years of age and older for immunization against influenza.* *The CDC has not made a preferential recommendation for any flu vaccine formulation directed toward this age group.5


Find out more at FLUAD.com/HCP FLUAD®


References: 1. FLUAD®


?


million


is a registered trademark of Seqirus UK Limited or its affiliates.


Manufactured by: Seqirus Vaccines Limited Speke, Liverpool, L249GR, UK Distributed by: Seqirus USA Inc., 25 Deforest Avenue, Summit, NJ 07901, USA


flu vaccine with adjuvant. Centers for Disease Control and Prevention website. https://www.cdc.gov/flu/protect/


vaccine/adjuvant.htm. Updated July 11, 2016. Accessed May 16, 2017. 2. O’Hagan D, Ott GS, De Gregorio E, Seubert A. The mechanism of action of MF59 - an innately attractive adjuvant formulation. Vaccine. 2012;30(29):4341-4348. 3. Call to action: reinvigorating influenza prevention in US adults age 65 years and older. National Foundation for Infectious Diseases website. http://www.nfid.org/flu-older-adults. Published September 2016. Accessed May 16, 2017. 4. Seqirus Inc. Data on file. Vaccine: V70; Fluad®; aTIV development safety update report. 2016. 5. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season. Centers for Disease Control and Prevention website. https://www.cdc.gov/mmwr/volumes/66/rr/ rr6602a1.htm. Accessed November 9, 2017.


US/FLUD/1117/0071 Visit www.ksrleads.com/?803hp-016


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82